uniQure to Participate in Multiple Upcoming Industry Conferences
July 26 2019 - 7:00AM
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced that it will participate in the following
upcoming conferences:
- 2019 Wells Fargo Biotech Corporate Access Day, July 30,
Boston, MA.• Members of uniQure’s management team will
attend and participate in one-on-one investor meetings throughout
the day on Tuesday, July 30.
- 11th Annual Bioprocessing Summit, August 12 – 16,
Boston, MA.• On Thursday, August
15th at 4:15 p.m. ET, Jacek Lubelski, Ph.D., VP Global
Pharmaceutical Development at uniQure, will be presenting “rAAV
Large Scale Manufacturing using the Baculovirus Expression Vector
Systems (BEVS) technology”
- Reimbursement and Access 2019 Conference, August 13 –
14, Philadelphia, PA.• Nick Li, Ph.D., MBA, Senior
Director Health Economics and Outcomes Research at uniQure, will be
participating in the panel discussion “Building Value and
Establishing Market Access Pathways for Cell and Gene Therapies” on
Wednesday, August 14th at 11:15 a.m. ET.
- Hemophilia Drug Development Conference (HDD), August 20
– 22, Boston, MA.• Sander van
Deventer, M.D., Ph.D., chief scientific officer at uniQure, will be
presenting on the “Significance of Neutralizing Antibodies in Gene
Therapy in Hemophilia” on Thursday, August 22nd at 9:00 a.m.
ET.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary and partnered gene therapies to treat patients with
hemophilia, Huntington’s disease and other severe genetic diseases.
www.uniQure.com
uniQure Contacts |
|
|
|
|
|
For Investors: |
|
For Media: |
|
|
|
Maria E. Cantor |
Eva M. Mulder |
Tom Malone |
Direct: 339-970-7536 |
Direct: +31 20 240 6103 |
Direct: 339-970-7558 |
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Mar 2024 to Apr 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Apr 2023 to Apr 2024